Aveo Capital Partners’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,125
| Closed | -$17.9K | – | 366 |
|
|
2023
Q4 | $17.9K | Sell |
1,125
-1,000
| -47% | -$15.9K | ﹤0.01% | 338 |
|
|
2023
Q3 | $40K | Hold |
2,125
| – | – | 0.01% | 330 |
|
|
2023
Q2 | $48K | Hold |
2,125
| – | – | 0.01% | 332 |
|
|
2023
Q1 | $54K | Hold |
2,125
| – | – | 0.01% | 332 |
|
|
2022
Q4 | $32.1K | Hold |
2,125
| – | – | ﹤0.01% | 327 |
|
|
2022
Q3 | $27K | Hold |
2,125
| – | – | ﹤0.01% | 270 |
|
|
2022
Q2 | $21K | Hold |
2,125
| – | – | ﹤0.01% | 268 |
|
|
2022
Q1 | $35K | Hold |
2,125
| – | – | 0.01% | 272 |
|
|
2021
Q4 | $54K | Buy |
2,125
+1,000
| +89% | +$25.4K | 0.01% | 281 |
|
|
2021
Q3 | $50K | Buy |
+1,125
| New | +$50K | 0.01% | 254 |
|